Skip to main content
Fig. 6 | Experimental Hematology & Oncology

Fig. 6

From: ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway

Fig. 6

Association between tumor somatic mutations and ZMIZ2 expression. (A) The waterfall plots showed top 15 gene alterations in the ZMIZ2 high and low expression group, respectively. (B) Violin plot shows no significant difference in tumor mutational burden between ZMIZ2 expression subgroups. (C) Box plots showing correlation of ZMIZ2 expression and TP53 mutation. (D) Kaplan-Meier overall survival curves of HCC patients with or without TP53 gene mutation. (E) Kaplan-Meier overall survival curves of HCC patients divided by TP53 mutation status and ZMIZ2 expression

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us